aluates Reports

$ 0.0

Automative

Typhoid Vi Polysaccharide Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-14J12249

Global Typhoid Vi Polysaccharide Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Typhoid Vi Polysaccharide Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14J12249

Report

September 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Emergent Biosolutions

Typhoid Vi Polysaccharide Vaccine - Market Size

The global market for Typhoid Vi Polysaccharide Vaccine was estimated to be worth US$ 524 million in 2023 and is forecast to a readjusted size of US$ 741.3 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030

Typhoid Vi Polysaccharide Vaccine - Market

Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Typhoid Vi Polysaccharide Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Typhoid Vi Polysaccharide Vaccine by region & country, by Type, and by Application.

The Typhoid Vi Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vi Polysaccharide Vaccine.

Market Segmentation

Scope of Typhoid Vi Polysaccharide Vaccine - Market Report

Report Metric	Details
Report Name	Typhoid Vi Polysaccharide Vaccine - Market
Forecasted market size in 2030	US$ 741.3 million
CAGR	5.1%
Forecasted years	2024 - 2030
Segment by Type:	Child Adult
Segment by Application	Government Institution Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi Pasteur SA, GSK, Emergent BioSolutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Typhoid Vi Polysaccharide Vaccine - Market size in 2030?

Ans: The Typhoid Vi Polysaccharide Vaccine - Market size in 2030 will be US$ 741.3 million.

Who are the main players in the Typhoid Vi Polysaccharide Vaccine - Market report?

Ans: The main players in the Typhoid Vi Polysaccharide Vaccine - Market are Sanofi Pasteur SA, GSK, Emergent BioSolutions

What are the Application segmentation covered in the Typhoid Vi Polysaccharide Vaccine - Market report?

Ans: The Applications covered in the Typhoid Vi Polysaccharide Vaccine - Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Typhoid Vi Polysaccharide Vaccine - Market report?

Ans: The Types covered in the Typhoid Vi Polysaccharide Vaccine - Market report are Child, Adult

Recommended Reports

Human Vaccine Markets

Vaccine Supply Chain

Adjuvants and Combinations

1 Market Overview

1.1 Typhoid Vi Polysaccharide Vaccine Product Introduction

1.2 Global Typhoid Vi Polysaccharide Vaccine Market Size Forecast

1.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030)

1.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Volume (2019-2030)

1.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Price (2019-2030)

1.3 Typhoid Vi Polysaccharide Vaccine Market Trends & Drivers

1.3.1 Typhoid Vi Polysaccharide Vaccine Industry Trends

1.3.2 Typhoid Vi Polysaccharide Vaccine Market Drivers & Opportunity

1.3.3 Typhoid Vi Polysaccharide Vaccine Market Challenges

1.3.4 Typhoid Vi Polysaccharide Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Typhoid Vi Polysaccharide Vaccine Players Revenue Ranking (2023)

2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024)

2.3 Global Typhoid Vi Polysaccharide Vaccine Players Sales Volume Ranking (2023)

2.4 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Typhoid Vi Polysaccharide Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Typhoid Vi Polysaccharide Vaccine

2.9 Typhoid Vi Polysaccharide Vaccine Market Competitive Analysis

2.9.1 Typhoid Vi Polysaccharide Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Typhoid Vi Polysaccharide Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Child

3.1.2 Adult

3.2 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type

3.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type

3.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Typhoid Vi Polysaccharide Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Typhoid Vi Polysaccharide Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Typhoid Vi Polysaccharide Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Institution

4.1.2 Private Sector

4.1.3 Other

4.2 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application

4.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application

4.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Typhoid Vi Polysaccharide Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Typhoid Vi Polysaccharide Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Typhoid Vi Polysaccharide Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region

5.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region

5.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Typhoid Vi Polysaccharide Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

5.4.2 North America Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

5.5.2 Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

5.7.2 South America Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value

6.2.1 Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.3.2 United States Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.4.2 Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.5.2 China Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.6.2 Japan Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.7.2 South Korea Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Typhoid Vi Polysaccharide Vaccine Sales Value, 2019-2030

6.9.2 India Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Typhoid Vi Polysaccharide Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi Pasteur SA

7.1.1 Sanofi Pasteur SA Company Information

7.1.2 Sanofi Pasteur SA Introduction and Business Overview

7.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Offerings

7.1.5 Sanofi Pasteur SA Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Emergent BioSolutions

7.3.1 Emergent BioSolutions Company Information

7.3.2 Emergent BioSolutions Introduction and Business Overview

7.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Offerings

7.3.5 Emergent BioSolutions Recent Development

8 Industry Chain Analysis

8.1 Typhoid Vi Polysaccharide Vaccine Industrial Chain

8.2 Typhoid Vi Polysaccharide Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Typhoid Vi Polysaccharide Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Typhoid Vi Polysaccharide Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Emergent Biosolutions

List of Tables

Table 1. Typhoid Vi Polysaccharide Vaccine Market Trends

Table 2. Typhoid Vi Polysaccharide Vaccine Market Drivers & Opportunity

Table 3. Typhoid Vi Polysaccharide Vaccine Market Challenges

Table 4. Typhoid Vi Polysaccharide Vaccine Market Restraints

Table 5. Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Typhoid Vi Polysaccharide Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Typhoid Vi Polysaccharide Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Typhoid Vi Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Typhoid Vi Polysaccharide Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Typhoid Vi Polysaccharide Vaccine

Table 13. Global Typhoid Vi Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Typhoid Vi Polysaccharide Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Typhoid Vi Polysaccharide Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Pasteur SA Company Information

Table 58. Sanofi Pasteur SA Introduction and Business Overview

Table 59. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Offerings

Table 61. Sanofi Pasteur SA Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Typhoid Vi Polysaccharide Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Emergent BioSolutions Company Information

Table 68. Emergent BioSolutions Introduction and Business Overview

Table 69. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Offerings

Table 71. Emergent BioSolutions Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. Typhoid Vi Polysaccharide Vaccine Downstream Customers

Table 75. Typhoid Vi Polysaccharide Vaccine Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Typhoid Vi Polysaccharide Vaccine Product Picture

Figure 2. Global Typhoid Vi Polysaccharide Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Typhoid Vi Polysaccharide Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Typhoid Vi Polysaccharide Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Typhoid Vi Polysaccharide Vaccine Report Years Considered

Figure 7. Global Typhoid Vi Polysaccharide Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Typhoid Vi Polysaccharide Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Typhoid Vi Polysaccharide Vaccine Revenue in 2023

Figure 10. Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Child Picture

Figure 12. Adult Picture

Figure 13. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Typhoid Vi Polysaccharide Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Typhoid Vi Polysaccharide Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Government Institution

Figure 19. Product Picture of Private Sector

Figure 20. Product Picture of Other

Figure 21. Global Typhoid Vi Polysaccharide Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Typhoid Vi Polysaccharide Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Typhoid Vi Polysaccharide Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Typhoid Vi Polysaccharide Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Typhoid Vi Polysaccharide Vaccine Sales Volume (%), (2019-2030)

Figure 38. United States Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Typhoid Vi Polysaccharide Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Typhoid Vi Polysaccharide Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Typhoid Vi Polysaccharide Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 59. Typhoid Vi Polysaccharide Vaccine Industrial Chain

Figure 60. Typhoid Vi Polysaccharide Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Typhoid Fever Vaccines Market Research Report 2024

Global Meningococcal Polysaccharide Vaccine Market Research Report 2025

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Oral Typhoid Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG Vaccine Market Insights Forecast to 2030

Global Preventive Vaccines Market Insights Forecast to 2030

TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Global Tetanus Vaccine Market Insights Forecast to 2030

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG Vaccination Market Research Report 2025

VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions